Published in Cancer on April 15, 1993
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
PC3 is a cell line characteristic of prostatic small cell carcinoma. Prostate (2011) 2.13
Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol (1994) 1.94
ACP Broadsheet No 146: August 1995. Macroscopic examination of prostatic specimens. J Clin Pathol (1995) 1.76
Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft. Am J Pathol (2002) 1.06
Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors. Neoplasia (2000) 1.01
Racial differences in the androgen/androgen receptor pathway in prostate cancer. J Natl Med Assoc (1999) 1.00
Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget (2015) 1.00
Prognostic factors in prostate cancer. Diagn Pathol (2006) 0.99
A role for the androgen-receptor in clinically localized and advanced prostate cancer. Best Pract Res Clin Endocrinol Metab (2008) 0.94
Java Web Start based software for automated quantitative nuclear analysis of prostate cancer and benign prostate hyperplasia. Biomed Eng Online (2005) 0.91
Computer based receptogram approach: an objective way of assessing immunohistochemistry of androgen receptor staining and its correlation with hormonal response in metastatic carcinoma of prostate. J Clin Pathol (2004) 0.82
Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications. Endocr Relat Cancer (2015) 0.81
Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer. Crit Rev Oncol Hematol (2012) 0.80
Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer. Clin Cancer Res (2016) 0.79
Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer. Cancers (Basel) (2015) 0.79
Challenges with luteinizing hormone-releasing hormone agonists: flare and surge. Rev Urol (2004) 0.75
Stromal Androgen Receptor in Prostate Cancer Development and Progression. Cancers (Basel) (2017) 0.75
Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia. Open Access Maced J Med Sci (2017) 0.75
The role of the nuclear matrix in the organization and function of DNA. Annu Rev Biophys Biophys Chem (1986) 2.07
The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissues. J Biol Chem (1980) 1.66
Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer (1991) 1.39
Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci U S A (1992) 1.28
The relationship of the nuclear matrix to cellular structure and function. Adv Enzyme Regul (1978) 1.23
Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol (1992) 1.21
Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res (1997) 1.14
Estrogen receptors in human prostate: evidence for multiple binding sites. J Clin Endocrinol Metab (1983) 1.14
The nuclear matrix of the prostate contains acceptor sites for androgen receptors. Endocrinology (1983) 1.05
Concepts related to salt resistant estradiol receptors in rat uterine nuclei: nuclear matrix. Biochem Biophys Res Commun (1977) 0.95
Expression of transforming growth factor-beta 1 in prostate cancer. Endocrinology (1994) 0.95
Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res (1995) 0.92
Androgen-receptor gene structure and function in prostate cancer. World J Urol (1996) 0.90
The regulation of nuclear DNA template restrictions by acidic polymers. Adv Enzyme Regul (1974) 0.90
Biological properties of the nuclear matrix: steroid hormone binding. Recent Prog Horm Res (1982) 0.89
Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy. Cancer (1991) 0.89
Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun (1994) 0.86
Immunogold probes for electron microscopy: evaluation of staining by fluorescence microscopy. J Histochem Cytochem (1985) 0.86
Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors. Cancer Res (1983) 0.85
Sexually dimorphic expression of estrogen receptors, but not of androgen receptors in human fetal external genitalia. J Clin Endocrinol Metab (1993) 0.84
The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines. J Urol (1984) 0.84
Androgen receptors and growth fraction in metastatic prostate cancer as predictors of time to tumour progression after hormonal therapy. Cancer Surv (1991) 0.80
Simultaneous measurement of progesterone and androgen receptors in human prostate: a microassay. J Clin Endocrinol Metab (1982) 0.80
Estrogen receptors in the nuclear matrix: direct demonstration using monoclonal antireceptor antibody. Endocrinology (1987) 0.80
Mitogenesis in normal human fibroblasts by polyinosinic . polycytidylic acid and other synthetic acidic polymers: enhancement of action by glucocorticoids. J Cell Physiol (1981) 0.80
Immunocytochemical localization of estrogen receptors in the normal male and female canine urinary tract and prostate. Endocrinology (1987) 0.79
Affinity chromatography of steroid-transforming enzymes. Methods Enzymol (1974) 0.78
The relationship of cellular structure and function: the matrix system. Prog Clin Biol Res (1981) 0.78
DNA synthesis in the canine prostate: effects of androgen and estrogen treatment. Prostate (1987) 0.77
Androgen receptor localization in the human prostate: demonstration of heterogeneity using a new method of steroid receptor autoradiography. J Steroid Biochem (1987) 0.77
Effects of transforming growth factor beta 1 on the adenylyl cyclase-cAMP pathway in prostate cancer. Growth Factors (1994) 0.76
The specific binding of estradiol to the nuclear matrix. Adv Exp Med Biol (1979) 0.75
A new method for labeling and autoradiographic localization of androgen receptors. J Histochem Cytochem (1987) 0.75
Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia. Prostate (1987) 0.75